22.07.2013 15:25:15

Endo Health Solutions Appoints Don DeGolyer As COO, Pharmaceuticals

(RTTNews) - Endo Health Solutions Inc. (ENDP) announced it has appointed Don DeGolyer as Chief Operating Officer, Pharmaceuticals, effective August 1, 2013. Most recently, DeGolyer served as President and CEO of Sandoz Inc., Novartis' North America generic pharmaceuticals unit.

Prior to joining Novartis in 2002, he spent 11 years at Johnson & Johnson in various roles of increasing responsibility, including Vice President of Marketing and Sales, and began his career at Pfizer, Inc.

Nachrichten zu Endo Health Solutions Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Endo Health Solutions Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!